Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment

Authors not listed

Boston University · 2023

Abstract

In this study, the investigators will use a novel electroencephalogram (EEG) system that participants will wear during a single in-person research session to investigate whether ERPs are now ready for validation as a tool clinicians can easily implement to increase diagnostic accuracy and confidence. This EEG will not be used to treat, cure, mitigate or diagnosis any disease and there will be no safety or efficacy data collected about the machine for any purpose including support of FDA submission. The investigators will compare the ERP data to that of neuropsychological testing in order to determine the degree of correlation between these two measures. Questionnaires on cognition, mood, and fluency will be administered prior to the EEG to establish a baseline. ERP data from the EEG session will be compared with the results of the neuropsychological battery in order to determine whether the implementation of ERPs in the existing workflow of clinicians can aid in diagnostic accuracy, thus altering clinical management.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-07 MST

Cite this

APA
Anonymous. (2023). The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment. <em>Boston University</em>. https://clinicaltrials.gov/study/NCT05673759
Vancouver
Anonymous. The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment. Boston University. 2023.
BibTeX
@misc{anon2023TheCli, title = {The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment}, author = {Anonymous}, journal = {Boston University}, year = {2023}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings